Monday, April 16, 2018

BRIEF-AstraZeneca says Updated Overall Survival Data For Lynparza(Olaparib) In Gbrca-Mutated Her2-Negative Metastatic Breast Cancer Presented At AACR

* UPDATED OVERALL SURVIVAL DATA FOR LYNPARZA® (OLAPARIB) IN GBRCA-MUTATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTED AT AACR
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)